APA (7th ed.) Citation

Fuchs, C. D., Dixon, E. D., Hendrikx, T., Mlitz, V., Wahlström, A., Ståhlman, M., . . . Trauner, M. (2022, September). Tetrahydroxylated bile acids improve cholestatic liver and bile duct injury in the Mdr2−/− mouse model of sclerosing cholangitis via immunomodulatory effects. Hepatology Communications.

Chicago Style (17th ed.) Citation

Fuchs, Claudia D., et al. "Tetrahydroxylated Bile Acids Improve Cholestatic Liver and Bile Duct Injury in the Mdr2−/− Mouse Model of Sclerosing Cholangitis via Immunomodulatory Effects." Hepatology Communications Sep. 2022.

MLA (9th ed.) Citation

Fuchs, Claudia D., et al. "Tetrahydroxylated Bile Acids Improve Cholestatic Liver and Bile Duct Injury in the Mdr2−/− Mouse Model of Sclerosing Cholangitis via Immunomodulatory Effects." Hepatology Communications, Sep. 2022.